Statistical Considerations. This is a two-center study, with equal numbers of patients treated at each site. All patients receive CaPVax injections and act as their own controls. The treatment plan is presented in Section 5.0. 37
Appears in 2 contracts
Sources: Clinical Trial Agreement (Northwest Biotherapeutics Inc), Clinical Trial Agreement (Northwest Biotherapeutics Inc)